Health Canada authorizes more flexible storage conditions for Pfizer-BioNTech COVID-19 vaccine
Today, Health Canada authorized a submission from Pfizer-BioNTech to allow its COVID-19 vaccine to be stored at regular refrigerated temperatures (2-8°C) at the point of use for up to one month. This change means that there will be more storage options available for the Pfizer-BioNTech vaccine, which will allow for more flexibility in distribution plans.